Table 1.
Comparison of clinical characteristics between Groups C1 and C2
| Characteristics | C1 (n = 199) | C2 (n = 208) | Total (N = 407) | P-value | FDR | |
|---|---|---|---|---|---|---|
| Age | ||||||
| Mean ±SD | 68.56 ±9.74 | 67.60 ±11.39 | 68.07 ±10.61 | |||
| Median [min-max] | 69.00 [43.00,90.00] | 68.00 [34.00,90.00] | 69.00 [34.00,90.00] | |||
| Diagnosis subtype, n (%) | 1.10E-07 | 8.00E-07 | ||||
| Non-papillary | 158 (38.82) | 112 (27.52) | 270 (66.34) | |||
| Papillary | 37 (9.09) | 95 (23.34) | 132 (32.43) | |||
| Gender, n (%) | 0.13 | 0.26 | ||||
| Female | 59 (14.50) | 47 (11.55) | 106 (26.04) | |||
| Male | 140 (34.40) | 161 (39.56) | 301 (73.96) | |||
| Histologic grade, n (%) | 1.50E-04 | 7.40E-04 | ||||
| High grade | 197 (48.40) | 186 (45.70) | 383 (94.10) | |||
| Low grade | 1 (0.25) | 20 (4.91) | 21 (5.16) | |||
| Pathologic M, n (%) | 0.01 | 0.03 | ||||
| M0 | 79 (19.41) | 117 (28.75) | 196 (48.16) | |||
| M1 | 8 (1.97) | 3 (0.74) | 11 (2.70) | |||
| Pathologic N, n (%) | 0.15 | 0.26 | ||||
| N0 | 113 (27.76) | 123 (30.22) | 236 (57.99) | |||
| N1 | 29 (7.13) | 17 (4.18) | 46 (11.30) | |||
| N2 | 39 (9.58) | 36 (8.85) | 75 (18.43) | |||
| N3 | 4 (0.98) | 4 (0.98) | 8 (1.97) | |||
| Pathologic T, n (%) | 1.80E-04 | 7.40E-04 | ||||
| T1 | 1 (0.27) | 2 (0.54) | 3 (0.80) | |||
| T2 | 41 (10.99) | 78 (20.91) | 119 (31.90) | |||
| T3 | 115 (30.83) | 78 (20.91) | 193 (51.74) | |||
| T4 | 33 (8.85) | 25 (6.70) | 58 (15.55) | |||
| Pathologic stage, n (%) | 9.00E-06 | 5.40E-05 | ||||
| Stage I | 0 (0.0e+0) | 2 (0.49) | 2 (0.49) | |||
| Stage II | 41 (10.07) | 89 (21.87) | 130 (31.94) | |||
| Stage III | 83 (20.39) | 56 (13.76) | 139 (34.15) | |||
| Stage IV | 75 (18.43) | 59 (14.50) | 134 (32.92) | |||